BRAF and colorectal carcinoma: This study demonstrated that a proteolysis targeting chimera (PROTAC), SJF-0628, is effective in directing the degradation of BRAF V600E in CRC and TNBC cancer cells, providing a tool to probe the effects of BRAF degradation and inhibition on cell signaling and proliferation.